Expedition Therapeutics Raises $165 Million in Oversubscribed Series A Financing to Advance Next-Generation DPP1 inhibitor for COPD

Expedition Therapeutics Raises $165 Million in Oversubscribed Series A Financing to Advance Next-Generation DPP1 inhibitor ...
MedPage Today on MSN

Asthma, COPD Inhalers Contributing More Greenhouse Gases

Metered-dose inhaler propellants have contributed a rising amount to greenhouse gases in the U.S. Emissions per inhaler ...
Fierce Biotech

Expedition resupplies for phase 2 COPD voyage with $165M series A

Expedition Therapeutics is gearing up for a phase 2 trek with a $165 million series A that closed Oct. 9. The new funding ...
New Atlas

Singing therapy hits the right note for chronically breathless patients

When breathing becomes a daily battle, even the simplest acts can feel exhausting. Now, a new study has found the key to ...
Contract Pharma

Expedition Therapeutics Raises $165 Million in Oversubscribed Series A

Expedition Therapeutics has closed a $165 million Series A financing round to support development of its lead candidate, EXPD ...

Inhalers produce carbon emissions equal to 530,000 cars on road annually, study finds

New JAMA study finds inhalers for asthma and COPD generate over 2 million metric tons of carbon emissions annually, ...

Merck Completes $10B Acquisition of Verona Pharma, Adds COPD Drug Ohtuvayre

Merck & Co. Inc. (NYSE:MRK) is one of the best growth stocks to buy now. On October 7, Merck & Co. announced the completion ...

The symptoms of Chronic obstructive pulmonary disease include coughing, shortness of breath, and fatigue

If you start to experience symptoms like chest pain, blue lips, or coughing up more than a teaspoon of blood, you should see ...

Inhalers drive carbon emissions equivalent to 530,000 cars each year, study shows

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new ...
EurekAlert!

UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study — the largest to date quantifying inhaler-related ...
Medindia

Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH), today announced that it will be presenting two rapid-fire presentations at CHEST 2025, the annual meeting of the ...